Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Africa News Observer.
Press releases published on June 13, 2025

Dr. Bernard WH Jennings Appointed to Board of Foundation for Youth and Economic Development
Dr. Bernard WH Jennings joins FYED Board to expand youth justice, economic access, and equity programs across Miami-Dade. MIAMI-DADE, FL, UNITED STATES, June 13, 2025 /EINPresswire.com/ -- In a significant development for Miami-Dade’s youth and economic …

Josh Maraney Shares 450+ Free Videos to teach Digital Marketing
Josh Maraney Surpasses 67,000 TikTok Followers and 20,000 on Instagram as His Free Marketing Videos Reach Millions Online JOHANNESBURG, GAUTENG, SOUTH AFRICA, June 13, 2025 /EINPresswire.com/ -- Josh Maraney, CEO of the digital marketing agency Top …

Aligos Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
SOUTH SAN FRANCISCO, Calif., June 13, 2025 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”, “Company”), a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and …

Processa Pharmaceuticals to Engage Potential Partners and Investors at BIO International Convention 2025
HANOVER, Md., June 13, 2025 (GLOBE NEWSWIRE) -- Processa Pharmaceuticals, Inc. (Nasdaq: PCSA), a clinical-stage pharmaceutical company developing Next Generation Cancer (NGC) therapies, today announced that members of its executive leadership team will …

Taseko Annual General Meeting Voting Results
VANCOUVER, British Columbia, June 13, 2025 (GLOBE NEWSWIRE) -- Taseko Mines Limited (TSX: TKO; NYSE American: TGB; LSE: TKO) (“Taseko” or the "Company") announces the voting results from its 2025 Annual General Meeting held Thursday, June 12, 2025 in …

Sensei Biotherapeutics Announces 1-for-20 Reverse Stock Split
BOSTON, June 13, 2025 (GLOBE NEWSWIRE) -- Sensei Biotherapeutics, Inc. (Nasdaq: SNSE), a clinical stage biotechnology company focused on the discovery and development of next-generation therapeutics for cancer patients, today announced that it will …

Altimmune Announces Multiple Presentations at Upcoming American Diabetes Association’s Scientific Sessions
GAITHERSBURG, Md., June 13, 2025 (GLOBE NEWSWIRE) -- Altimmune, Inc. (Nasdaq: ALT), a late clinical-stage biopharmaceutical company developing novel peptide-based therapeutics for liver and cardiometabolic diseases, today announced an oral presentation and …

Arvinas Presents Preclinical Data for PROTAC BCL6 Degrader, ARV-393, at the European Hematology Association 2025 Congress
– ARV-393 demonstrated significant single-agent activity in models of nodal T-follicular helper cell lymphoma, angioimmunoblastic-type (also known as AITL) and transformed follicular lymphoma – – In combination with small molecule inhibitors, ARV-393 …

ORLADEYO® (berotralstat) Approved in Colombia
RESEARCH TRIANGLE PARK, N.C., June 13, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the National Institute of Drug and Food Surveillance (INVIMA) in Colombia has granted approval for oral, once-daily ORLADEYO …

NexGold Infill Drilling Intersects 25.79 g/t Gold Over 4.5 Metres and 18.09 g/t Gold over 3.0 Metres at the Goldboro Gold Project
TORONTO, June 13, 2025 (GLOBE NEWSWIRE) -- NexGold Mining Corp. (TSXV: NEXG; OTCQX: NXGCF) (“NexGold” or the “Company”) is pleased to provide an update on its ongoing 25,000-metre diamond drill program initially announced on January 22, 2025 at the Company …

Robex remains on track for first gold at Kiniero in Q4 2025
Highlights: Construction at Robex’s Kiniero Gold Project, Guinea, remains on schedule and budget with first gold pour on track for Q4 2025. Project remains LTI free (lost time injury). All project engineering and detail design completed. Phase 1 grade …

ITM to Provide COMPETE Trial Insights at SNMMI 2025 Annual Meeting in Oral Presentation and Satellite Symposium
Garching / Munich, Germany, June 13, 2025 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced that it will provide further analysis from its recently completed Phase 3 COMPETE trial in an oral …

Aya Gold & Silver Announces Filing of Prospectus Supplement
NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. The base shelf prospectus and the prospectus supplement are accessible on SEDAR+. Any amendment to the foregoing documents will be accessible within one …

Brunswick Exploration Announces AGM Results
MONTREAL, June 12, 2025 (GLOBE NEWSWIRE) -- Brunswick Exploration Inc. (“BRW” or the “Corporation”) is pleased to announce the results of its annual general meeting (“AGM”) of shareholders held on June 12, 2025. Shareholders holding a total of 80,309,202 …

Brunswick Exploration annonce les résultats de son assemblée générale annuelle
MONTRÉAL, 12 juin 2025 (GLOBE NEWSWIRE) -- Brunswick Exploration Inc. (« BRW » ou la « Société ») est heureuse d'annoncer les résultats de son assemblée générale annuelle (« AGA ») des actionnaires tenue le 12 juin 2025. Les actionnaires détenant un total …